Pharmacokinetics and Safety/Tolerability Profile of CKD-379

Clinical trial NCT05452525 · COMPLETED

Trial details

NCT number: NCT05452525
Sponsor: Chong Kun Dang Pharmaceutical
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Type II Diabetes Mellitus

Start date: 2022-07-26
Primary completion: 2022-08-27
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.